Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease
In order to explore effective acetyl and butyrylcholinesterase enzyme inhibitors, a library of fifteen synthetic 1,2,4-substituted triazoles (5–19) was established and characterized using IR and NMR spectroscopic techniques. Compounds 9 and 16 were found to be the most potent AChE (IC50 = 38.91 ± 0....
| id |
Ali S.; Siddiqui S.Z.; Khan K.M.; Abbasi M.A.; Aziz-ur-Rehman; Saad S.M.; Shah S.A.A.; Zaib Saleem R.S.; Ashraf M. |
|---|---|
| spelling |
Ali S.; Siddiqui S.Z.; Khan K.M.; Abbasi M.A.; Aziz-ur-Rehman; Saad S.M.; Shah S.A.A.; Zaib Saleem R.S.; Ashraf M. 2-s2.0-85136203736 Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease 2022 Journal of the Iranian Chemical Society 19 11 10.1007/s13738-022-02617-5 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136203736&doi=10.1007%2fs13738-022-02617-5&partnerID=40&md5=589609b1bc9159007cbde7e5a83479d0 In order to explore effective acetyl and butyrylcholinesterase enzyme inhibitors, a library of fifteen synthetic 1,2,4-substituted triazoles (5–19) was established and characterized using IR and NMR spectroscopic techniques. Compounds 9 and 16 were found to be the most potent AChE (IC50 = 38.91 ± 0.52 µM) and BChE (IC50 = 42.74 ± 0.42 µM) inhibitors, against the standard eserine (IC50 = 39.19 ± 0.05 µM for AChE and 46.62 ± 0.08 µM for BChE). In addition, binding interactions of potent inhibitors of AChE and BChE were studied using molecular docking. Compounds 9 and 16 were identified as promising dual inhibitors for AChE and BChE that may further be investigated to serve as lead molecules against Alzheimer’s disease. © 2022, Iranian Chemical Society. Springer Science and Business Media Deutschland GmbH 1735207X English Article |
| author |
2-s2.0-85136203736 |
| spellingShingle |
2-s2.0-85136203736 Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease |
| author_facet |
2-s2.0-85136203736 |
| author_sort |
2-s2.0-85136203736 |
| title |
Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease |
| title_short |
Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease |
| title_full |
Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease |
| title_fullStr |
Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease |
| title_full_unstemmed |
Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease |
| title_sort |
Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer’s disease |
| publishDate |
2022 |
| container_title |
Journal of the Iranian Chemical Society |
| container_volume |
19 |
| container_issue |
11 |
| doi_str_mv |
10.1007/s13738-022-02617-5 |
| url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136203736&doi=10.1007%2fs13738-022-02617-5&partnerID=40&md5=589609b1bc9159007cbde7e5a83479d0 |
| description |
In order to explore effective acetyl and butyrylcholinesterase enzyme inhibitors, a library of fifteen synthetic 1,2,4-substituted triazoles (5–19) was established and characterized using IR and NMR spectroscopic techniques. Compounds 9 and 16 were found to be the most potent AChE (IC50 = 38.91 ± 0.52 µM) and BChE (IC50 = 42.74 ± 0.42 µM) inhibitors, against the standard eserine (IC50 = 39.19 ± 0.05 µM for AChE and 46.62 ± 0.08 µM for BChE). In addition, binding interactions of potent inhibitors of AChE and BChE were studied using molecular docking. Compounds 9 and 16 were identified as promising dual inhibitors for AChE and BChE that may further be investigated to serve as lead molecules against Alzheimer’s disease. © 2022, Iranian Chemical Society. |
| publisher |
Springer Science and Business Media Deutschland GmbH |
| issn |
1735207X |
| language |
English |
| format |
Article |
| accesstype |
|
| record_format |
scopus |
| collection |
Scopus |
| _version_ |
1828987867761737728 |